Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries

BACKGROUND: Tafenoquine is a long half-life primaquine analog being developed for malaria prophylaxis. The US Army recently performed a unified analysis of efficacy in preparation for a regulatory submission, utilizing legacy data from three placebo-controlled studies conducted in the late 1990s and...

Descripción completa

Detalles Bibliográficos
Autores principales: Dow, Geoffrey S., Liu, Jun, Lin, Gina, Hetzell, Brian, Thieling, Sarah, McCarthy, William F., Tang, Douglas, Smith, Bryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661991/
https://www.ncbi.nlm.nih.gov/pubmed/26610844
http://dx.doi.org/10.1186/s12936-015-0991-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661991/
https://www.ncbi.nlm.nih.gov/pubmed/26610844
http://dx.doi.org/10.1186/s12936-015-0991-x

Ejemplares similares